Menu
Recruiting NCT07459764

Body Clocks - Coordination of Peripheral and Central Oscillators

Observational Circadian Dysregulation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Circadian Dysregulation. Basic parameters: 18 years — 30 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Confluence of Sleep, Circadian Rhythms, and the Menstrual Cycle on Injury Risk in Women

Overview

The investigators are conducting an observational trial examining young women over the course of 28 days in which we are monitoring movement, sleep, heart rate, oxygen saturation, gut physiology, light, and menstrual cycle. The inter- and independence of the cyclicity of these variables with each other, the circadian cycle, the menstrual cycle, and the sleep cycle will be tested.

Detailed description

For 28 days, women will wear devices to capture: ambient light exposure, lower limb biomechanics, sleep, oxygen saturation, heart rate, temperature, and gut physiology.

Twice during the study, women will have saliva collected for 7 hours under dim light conditions in order to determine melatonin concentrations. During this 7-hour period, two blood draws for determination of proteomic profiles will also occur.

Daily urine samples will be tested for LH until the presence of the LH surge to help identify menstrual phase.

Primary outcome measures

  • Stride time [Time frame: 28 days]
Secondary outcome measures (1)
  • Sleep [Time frame: 28 days]

Eligibility criteria

Inclusion criteria

  • Regular menstrual cycle (21-35 days)
  • 18-30 years old

Exclusion criteria

  • Neuromuscular or neurodegenerative disease
  • Gut disorders
  • circadian sleep disorders
  • prescription medications affecting sleep
  • recovering from physical injury
  • taking hormonal birth control

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Stanford University — Stanford

Identifiers

NCT: NCT07459764 · IRB-66230

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗